biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for canc

Biocept, Inc.

Sold all BIOC

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Bought 144% more BIOC

Brian Stainbrook

New position in BIOC

Bought <1% more BIOC

Bought 6% more BIOC

Bought 7% more BIOC

Bought 8% more BIOC

Bought 9% more BIOC

Bought 10% more BIOC

Bought 11% more BIOC

Bought 12% more BIOC

Bought 14% more BIOC

Bought 17% more BIOC

Bought 20% more BIOC

Bought 25% more BIOC

Bought 33% more BIOC